Tellus Therapeutics, Inc.
Pharmaceutical company · Durham, North Carolina, United States
Tellus Therapeutics, Inc. is a pharmaceutical company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $696,593 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $16 million sold in a notice filed in 2023.
Tellus Therapeutics at a glance
What does Tellus Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $696,593 in total (2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $16 million sold (2023).
Frequently asked questions about Tellus Therapeutics
Where is Tellus Therapeutics headquartered?
Tellus Therapeutics, Inc. is headquartered in Durham, North Carolina, United States.
What does Tellus Therapeutics do?
Tellus Therapeutics, Inc. is a pharmaceutical company.
When was Tellus Therapeutics founded?
The earliest incorporation on record for Tellus Therapeutics, Inc. is in 2022, according to public company registers.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
- G1 Therapeutics, Inc.Durham, North Carolina, United States
- Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences